These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14680755)

  • 1. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.
    Pałucha A; Tatarczyńska E; Brański P; Szewczyk B; Wierońska JM; Kłak K; Chojnacka-Wójcik E; Nowak G; Pilc A
    Neuropharmacology; 2004 Feb; 46(2):151-9. PubMed ID: 14680755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
    Kłak K; Pałucha A; Brański P; Sowa M; Pilc A
    Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
    Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A
    Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Pharmacol Rep; 2006; 58(6):820-6. PubMed ID: 17220539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
    Wierońska JM; Szewczyk B; Pałucha A; Brański P; Zieba B; Smiałowska M
    Pharmacol Rep; 2005; 57(6):734-43. PubMed ID: 16382191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
    Chapman AG; Talebi A; Yip PK; Meldrum BS
    Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
    Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M
    Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
    Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A
    Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
    Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
    Neuropharmacology; 2016 Mar; 102():276-94. PubMed ID: 26647070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation.
    Zhang C; Marek GJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):437-47. PubMed ID: 17021259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
    Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
    Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus.
    de Mendonça A; Ribeiro JA
    Br J Pharmacol; 1997 Aug; 121(8):1541-8. PubMed ID: 9283686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans.
    Uehara S; Muroyama A; Echigo N; Morimoto R; Otsuka M; Yatsushiro S; Moriyama Y
    Diabetes; 2004 Apr; 53(4):998-1006. PubMed ID: 15047615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.
    Lopez S; Turle-Lorenzo N; Acher F; De Leonibus E; Mele A; Amalric M
    J Neurosci; 2007 Jun; 27(25):6701-11. PubMed ID: 17581957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.
    Jantas D; Gręda A; Gołda S; Korostyński M; Lasoń W
    Neuropharmacology; 2016 Dec; 111():195-211. PubMed ID: 27600687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.